News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
643,099 Results
Type
Article (54961)
Company Profile (302)
Press Release (587828)
Multimedia
Podcasts (134)
Webinars (22)
Section
Business (170566)
Career Advice (2466)
Deals (31185)
Drug Delivery (133)
Drug Development (79823)
Employer Resources (158)
FDA (16757)
Job Trends (13517)
News (306082)
Policy (32435)
Tag
Academia (2706)
Academic (1)
Accelerated approval (21)
Adcomms (35)
Allergies (128)
Alliances (44353)
ALS (155)
Alzheimer's disease (1715)
Antibody-drug conjugate (ADC) (265)
Approvals (16819)
Artificial intelligence (470)
Autoimmune disease (120)
Automation (29)
Bankruptcy (328)
Best Places to Work (10542)
BIOSECURE Act (23)
Biosimilars (173)
Biotechnology (194)
Bladder cancer (138)
Brain cancer (53)
Breast cancer (517)
Cancer (4203)
Cardiovascular disease (382)
Career advice (2081)
Career pathing (38)
CAR-T (242)
CDC (57)
Cell therapy (676)
Cervical cancer (34)
Clinical research (67154)
Collaboration (1414)
Company closure (4)
Compensation (984)
Complete response letters (64)
COVID-19 (2871)
CRISPR (86)
C-suite (636)
Cystic fibrosis (141)
Data (5185)
Decentralized trials (2)
Denatured (34)
Depression (119)
Diabetes (462)
Diagnostics (6415)
Digital health (33)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (216)
Drug pricing (196)
Drug shortages (33)
Duchenne muscular dystrophy (214)
Earnings (69393)
Editorial (57)
Employer branding (20)
Employer resources (143)
Events (98457)
Executive appointments (932)
FDA (19385)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (21)
Funding (1265)
Gene editing (191)
Generative AI (36)
Gene therapy (573)
GLP-1 (1031)
Government (4654)
Grass and pollen (8)
Guidances (372)
Healthcare (17238)
HIV (51)
Huntington's disease (42)
IgA nephropathy (76)
Immunology and inflammation (266)
Immuno-oncology (25)
Indications (64)
Infectious disease (3128)
Inflammatory bowel disease (196)
Inflation Reduction Act (13)
Influenza (102)
Intellectual property (206)
Interviews (456)
IPO (15441)
IRA (56)
Job creations (3379)
Job search strategy (1713)
Kidney cancer (16)
Labor market (75)
Layoffs (621)
Leadership (36)
Legal (7412)
Liver cancer (93)
Longevity (12)
Lung cancer (608)
Lymphoma (298)
Machine learning (32)
Management (53)
Manufacturing (632)
MASH (161)
Medical device (12541)
Medtech (12572)
Mergers & acquisitions (16673)
Metabolic disorders (1212)
Multiple sclerosis (147)
NASH (23)
Neurodegenerative disease (264)
Neuropsychiatric disorders (76)
Neuroscience (2835)
NextGen: Class of 2025 (5812)
Non-profit (4465)
Now hiring (37)
Obesity (582)
Opinion (276)
Ovarian cancer (143)
Pain (164)
Pancreatic cancer (183)
Parkinson's disease (255)
Partnered (25)
Patents (434)
Patient recruitment (348)
Peanut (55)
People (51597)
Pharmaceutical (69)
Pharmacy benefit managers (28)
Phase I (20555)
Phase II (29420)
Phase III (22641)
Pipeline (3370)
Policy (304)
Postmarket research (2634)
Preclinical (8727)
Press Release (49)
Prostate cancer (212)
Psychedelics (51)
Radiopharmaceuticals (251)
Rare diseases (729)
Real estate (4943)
Recruiting (65)
Regulatory (24191)
Reports (41)
Research institute (2488)
Resumes & cover letters (409)
Rett syndrome (21)
RNA editing (16)
RSV (78)
Schizophrenia (142)
Series A (214)
Series B (160)
Service/supplier (10)
Sickle cell disease (87)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (42)
Startups (3327)
State (1)
Stomach cancer (18)
Supply chain (99)
Tariffs (96)
The Weekly (99)
Vaccines (1057)
Venture capital (74)
Weight loss (408)
Women's health (58)
Worklife (21)
Date
Last 7 days (638)
Last 30 days (3368)
Last 365 days (30821)
2025 (28308)
2024 (34825)
2023 (39047)
2022 (49934)
2021 (53849)
2020 (51460)
2019 (41907)
2018 (31780)
2017 (31572)
2016 (30472)
2015 (34220)
2014 (27052)
2013 (22277)
2012 (23661)
2011 (23921)
2010 (22154)
Location
Africa (830)
Alabama (68)
Alaska (6)
Arizona (227)
Arkansas (11)
Asia (38230)
Australia (6653)
California (9863)
Canada (2702)
China (930)
Colorado (395)
Connecticut (458)
Delaware (272)
Europe (90941)
Florida (1452)
Georgia (306)
Hawaii (3)
Idaho (58)
Illinois (708)
India (47)
Indiana (442)
Iowa (20)
Japan (338)
Kansas (114)
Kentucky (32)
Louisiana (24)
Maine (74)
Maryland (1295)
Massachusetts (7282)
Michigan (264)
Minnesota (546)
Mississippi (5)
Missouri (115)
Montana (26)
Nebraska (24)
Nevada (103)
New Hampshire (68)
New Jersey (2713)
New Mexico (22)
New York (2640)
North Carolina (1341)
North Dakota (8)
Northern California (4713)
Ohio (277)
Oklahoma (18)
Oregon (37)
Pennsylvania (1987)
Puerto Rico (13)
Rhode Island (35)
South America (1169)
South Carolina (55)
South Dakota (1)
Southern California (3788)
Tennessee (141)
Texas (1497)
United States (35316)
Utah (283)
Virginia (241)
Washington D.C. (76)
Washington State (801)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
643,099 Results for "parkinson s disease foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program
Novartis is licensing ARO-SNCA, a preclinical siRNA therapy for synucleinopathies, a group of neurodegenerative disorders including Parkinson’s disease.
September 2, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
October 9, 2025
·
8 min read
Press Releases
Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
November 6, 2025
·
5 min read
Press Releases
Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson’s Patients at International Congress of Parkinson’s Disease and Movement Disorders®
October 7, 2025
·
7 min read
Press Releases
Booster Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to Advance New Class of Proteasome Activator Medicines Towards First-in-Human Phase 1 Study
November 14, 2025
·
3 min read
Press Releases
Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson’s Disease and Related Disorders
November 21, 2025
·
3 min read
Press Releases
Cerevance to Present Phase 2 Data on Solengepras in Parkinson’s Disease at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
September 23, 2025
·
3 min read
Press Releases
Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TRPML1 Agonist to Treat Parkinson’s Disease
August 6, 2025
·
1 min read
Press Releases
Rune Labs and Parkinson’s Foundation Launch First Clinical Program to Correlate Genetic and Digital Biomarkers for Parkinson’s Disease
May 29, 2025
·
6 min read
Press Releases
Herantis Pharma presents positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease
October 7, 2025
·
8 min read
1 of 64,310
Next
